Mohamed S. El Masry

Mohamed S. El Masry

Auto-generated profile, based on publicly available information

Mohamed S. El Masry

McGowan Institute for Regenerative Medicine, University of Pittsburgh, Pittsburgh, PA, United States

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 September 2020 in ACS Nano
Verified
Journal Article
Closed access
XZXiaoju Zhou
Xiaoju Zhou
BBBrooke A. Brown
Brooke A. Brown
ASAmanda P. Siegel
Amanda P. Siegel
MMMohamed S. El Masry
Mohamed S. El Masry
XZXuyao Zeng
Xuyao Zeng
SGSubhadip Ghatak
Subhadip Ghatak

20 December 2023 in Wound Repair and Regeneration
Verified
Journal Article
Open access
LGLisa J. Gould
Lisa J. Gould
JAJenny Alderden
Jenny Alderden
RARummana Aslam
Rummana Aslam
ABAdrian Barbul
Adrian Barbul
KBKath M. Bogie
Kath M. Bogie
TYTracey L. Yap
Tracey L. Yap
The major populations at risk for developing pressure ulcers are older adults who have multiple risk factors that increase their vulnerability, people who are critically ill and those with spinal cord injury/disease. The reported prevalence of pressure ulcers in the United States is 2.5 million. However, this estimate is derived from acute care facilities and does not include people who are living at home or in nursing facilities. Despite the implementation of hospital and facility‐based preventive measures, the incidence of pressure ulcers has not decreased in decades. In addition to the burden of pain, infection and death, it is estimated that hospital‐acquired pressure ulcers cost the health system $26.8 billion annually with over 50% of the cost attributed to treating Stage 3 and 4 pressure injuries. Thus, it is critical to examine the literature and develop guidelines that will improve the outcomes of this complex and costly condition. This guideline update is a compendium of the best available evidence for the treatment of Pressure Ulcers published since the last update in 2015 and includes a new section based on changing demographics entitled ‘Palliative wound care for seriously ill patients with pressure ulcers’. The overall goal of the Wound Healing Society Guideline project is to present clear, concise and commercial free guidelines that clinicians can use to guide care, that researchers can use to develop studies that will improve treatment and that both clinicians and researchers can use to understand the gaps in our knowledge base.

27 September 2018 in The FASEB Journal
Verified
Journal Article
Open access
PDF file
MMMohamed S. El Masry
Mohamed S. El Masry
SCScott Chaffee
Scott Chaffee
PGPiya Das Ghatak
Piya Das Ghatak
SMShomita S. Mathew-Steiner
Shomita S. Mathew-Steiner
ADAmitava Das
Amitava Das
CSChandan K. Sen
Chandan K. Sen
Decellularized matrices of biologic tissue have performed well as wound care dressings. Extracellular matrix‐based dressings are subject to rapid degradation by excessive protease activity at the wound environment. Stabilized, acellular, equine pericardial collagen matrix (sPCM) wound care dressing is flexible cross‐linked proteolytic enzyme degradation resistant. sPCM was structurally characterized utilizing scanning electron and atomic force microscopy. In murine excisional wounds, sPCM was effective in mounting an acute inflammatory response. Postwound inflammation resolved rapidly, as indicated by elevated levels of IL‐10, arginase‐1, and VEGF, and lowering of IL‐lβ and TNF‐α. sPCM induced antimicrobial proteins S100A9 and β‐defensin‐1 in keratinocytes. Adherence of Pseudomonas aeruginosa and Staphylococcus aureus on sPCM pre‐exposed to host immune cells in vivo was inhibited. Excisional wounds dressed with sPCM showed complete closure at d 14, while control wounds remained open. sPCM accelerated wound re‐epithelialization. sPCM not only accelerated wound closure but also improved the quality of healing by increased collagen deposition and maturation. Thus, sPCM is capable of presenting scaffold functionality during the course of wound healing. In addition to inducing endogenous antimicrobial defense systems, the dressing itself has properties that minimize biofilm formation. It mounts robust inflammation, a process that rapidly resolves, making way for wound healing to advance.—El Masry, M. S., Chaffee, S., Das Ghatak, P., Mathew‐Steiner, S. S., Das, A., Higuita‐Castro, N., Roy, S., Anani, R. A., Sen, C. K. Stabilized collagen matrix dressing improves wound macrophage function and epithelialization. FASEB J. 33, 2144–2155 (2019). www.fasebj.org

1 September 2018 in Molecular Therapy
Verified
Journal Article
Open access
JLJilong Li
Jilong Li
SGSubhadip Ghatak
Subhadip Ghatak
MMMohamed S. El Masry
Mohamed S. El Masry
ADAmitava Das
Amitava Das
YLYang Liu
Yang Liu
CSChandan K. Sen
Chandan K. Sen
Lyophilized keratinocyte-targeted nanocarriers (TLNκ) loaded with locked nucleic acid (LNA) modified anti-miR were developed for topical application to full thickness burn injury. TLNκ were designed to selectively deliver LNA-anti-miR-107 to keratinocytes using the peptide sequence ASKAIQVFLLAG. TLNκ employed DOTAP/DODAP combination pH-responsive lipid components to improve endosomal escape. To minimize interference of clearance by non-targeted cells, especially immune cells in the acute wound microenvironment, surface charge was neutralized. Lyophilization was performed to extend the shelf life of the lipid nanoparticles (LNPs). Encapsulation efficiency of anti-miR in lyophilized TLNκ was estimated to be 96.54%. Cargo stability of lyophilized TLNκ was tested. After 9 days of loading with anti-miR-210, TLNκ was effective in lowering abundance of the hypoxamiR miR-210 in keratinocytes challenged with hypoxia. Keratinocyte uptake of DiD-labeled TLNκ was selective and exceeded 90% within 4 hr. Topical application of hydrogel-dispersed lyophilized TLNκ encapsulating LNA anti-miR-107 twice a week significantly accelerated wound closure and restoration of skin barrier function. TLNκ/anti-miR-107 application depleted miR-107 and upregulated dicer expression, which accelerated differentiation of keratinocytes. Expression of junctional proteins such as claudin-1, loricrin, filaggrin, ZO-1, and ZO-2 were significantly upregulated following TLNκ/anti-miR-107 treatment. These LNPs are promising as topical therapeutic agents in the management of burn injury.

1 November 2017 in Molecular Therapy
Verified
Journal Article
Open access
NANoha S. Ahmed
Noha S. Ahmed
SGSubhadip Ghatak
Subhadip Ghatak
MMMohamed S. El Masry
Mohamed S. El Masry
SGSurya C. Gnyawali
Surya C. Gnyawali
SRSashwati Roy
Sashwati Roy
SKSavita Khanna
Savita Khanna
Unlike the epidermis, which regenerates continually, hair follicles anchored in the subcutis periodically regenerate by spontaneous repetitive cycles of growth (anagen), degeneration (catagen), and rest (telogen). The loss of hair follicles in response to injuries or pathologies such as alopecia endangers certain inherent functions of the skin. Thus, it is of interest to understand mechanisms underlying follicular regeneration in adults. In this work, a phytochemical rich in the natural vitamin E tocotrienol (TRF) served as a productive tool to unveil a novel epidermal pathway of hair follicular regeneration. Topical TRF application markedly induced epidermal hair follicle development akin to that during fetal skin development. This was observed in the skin of healthy as well as diabetic mice, which are known to be resistant to anagen hair cycling. TRF suppressed epidermal E-cadherin followed by 4-fold induction of β-catenin and its nuclear translocation. Nuclear β-catenin interacted with Tcf3. Such sequestration of Tcf3 from its otherwise known function to repress pluripotent factors induced the plasticity factors Oct4, Sox9, Klf4, c-Myc, and Nanog. Pharmacological inhibition of β-catenin arrested anagen hair cycling by TRF. This work reports epidermal E-cadherin/β-catenin as a novel pathway capable of inducing developmental folliculogenesis in the adult skin.